General AML

SOHO 2019 | In what ways can the immune system be involved in treating patients with AML?

L: English

During SOHO 2019, Houston, US, the AML Global Portal were pleased to speak to Dr Farhad Ravandi from The University of Texas, MD Anderson Cancer Center, Houston, US, about ways the immune system can be involved in the treatment of patients with AML. He discusses the potential use of immune-based therapies, such as CAR T-cells, monoclonal antibody-drug conjugates, radioimmunoconjugates, and bispecific antibodies, to reduce MRD.